在非小细胞肺癌中,MAFF通过抑制YAP1核转位来抑制血管生成
Yao Ding1, Shizi Wang1, Rui Hu1
1School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, Guangxi, China.
PeerJ
|November 25, 2025
概括
MAFF通过抑制YAP1核转位来抑制非小细胞肺癌 (NSCLC) 血管生成. 这一发现凸显了MAFF作为NSCLC治疗的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 血管新生对于非小细胞肺癌 (NSCLC) 的进展至关重要.
- 在NSCLC血管生成中MAFF和YES相关蛋白1 (YAP1) 的作用需要进一步阐明.
研究的目的:
- 研究MAFF和YAP1在NSCLC血管生成中的调节作用.
- 探索MAFF通过YAP1核转位抑制抑制血管生成的机制.
主要方法:
- 在NSCLC中进行MAFF表达分析的生物信息学和免疫组织化学 (IHC).
- 在体外细胞测定 (增殖,迁移,血管生成) 和西部斑 (WB) /免疫光 (IF) 针对YAP1,VEGF和CTGF.
- 在体内裸体老鼠异种移植模型评估瘤生长抑制.
主要成果:
- 在NSCLC中,MAFF的调控下降,与晚期和更高的微血管密度 (MVD) 相相关.
- 过度表达MAFF抑制了NSCLC细胞的增殖,迁移和血管生成,降低了YAP1,VEGF和CTGF的调节.
- MAFF抑制了YAP1的核转位,并在体内减少了瘤的生长,抑制了YAP1的信号通路.
结论:
- MAFF通过抑制YAP1核转位来抑制NSCLC血管生成.
- MAFF降低了VEGF和CTGF的调节,表明其作为NSCLC治疗点的潜力.
更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
7.3K
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.4K
相关概念视频
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Mechanism of Angiogenesis
6.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.6K
The Intrinsic Apoptotic Pathway
8.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.1K
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
